Cancel
Known information
- Received a BA from the University of Southern Maine where he studied general biology
- Investigated novel synthetic lethality relationships in DNA damage and repair pathways with the D’Andrea Laboratory at the Dana Farber Cancer Institute
- Focuses on drug screening and model development at Arpeggio
About Arpeggio Bio
Arpeggio Bio, based in Boulder, CO, specializes in drug discovery targeting transcription factors with AI and RNA-sequencing technologies. The company, with a team of 20, collaborates with industry giants like J&J and FORMA, focusing on diseases such as IO-resistant melanoma and rare genetic disorders.
Report inaccurate information
